Business Description
Zydus Lifesciences Ltd
ISIN : INE010B01027
Share Class Description:
BOM:532321: Ordinary SharesTotal Employee Number:
27,917Compare
Compare
Traded in other countries / regions
532321.India IPO Date
2000-04-18Description
Zydus Lifesciences Ltd is a specialty and generic drug manufacturing company. It is engaged in the research, development, production, marketing, and distribution of pharmaceutical products. The product portfolio of the company includes Active Pharmaceutical Ingredients (API), human formulations, animal health and veterinary, and consumer health and wellness products. Its products are marketed under brands like Amlodac, Inditel, Pivasta, and others. The company's operating segments are: Pharmaceuticals, which derives key revenue, and Consumer products. Geographically, it generates maximum revenue from the United States, followed by India, and other countries.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.59 | |||||
Equity-to-Asset | 0.52 | |||||
Debt-to-Equity | 0.46 | |||||
Debt-to-EBITDA | 1.48 | |||||
Interest Coverage | 13.18 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 4.04 | |||||
Beneish M-Score | -1.96 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 16.9 | |||||
3-Year EBITDA Growth Rate | 35.5 | |||||
3-Year EPS without NRI Growth Rate | 46.2 | |||||
3-Year Book Growth Rate | 15.9 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 9.03 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 64.23 | |||||
9-Day RSI | 65.72 | |||||
14-Day RSI | 65.66 | |||||
3-1 Month Momentum % | 19.93 | |||||
6-1 Month Momentum % | 22.68 | |||||
12-1 Month Momentum % | 12.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.27 | |||||
Quick Ratio | 0.91 | |||||
Cash Ratio | 0.47 | |||||
Days Inventory | 238.95 | |||||
Days Sales Outstanding | 65.58 | |||||
Days Payable | 127 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.95 | |||||
Dividend Payout Ratio | 0.2 | |||||
3-Year Dividend Growth Rate | 63.9 | |||||
Forward Dividend Yield % | 0.09 | |||||
5-Year Yield-on-Cost % | 0.96 | |||||
3-Year Average Share Buyback Ratio | 0.2 | |||||
Shareholder Yield % | -7.27 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 72.71 | |||||
Operating Margin % | 21.66 | |||||
Net Margin % | 18.86 | |||||
EBITDA Margin % | 31.69 | |||||
FCF Margin % | -2.08 | |||||
OCF Margin % | 7.92 | |||||
ROE % | 19.8 | |||||
ROA % | 11.08 | |||||
ROIC % | 12.16 | |||||
3-Year ROIIC % | 9.57 | |||||
ROC (Joel Greenblatt) % | 54.84 | |||||
ROCE % | 20.7 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 22.75 | |||||
Forward PE Ratio | 27.72 | |||||
PE Ratio without NRI | 21.05 | |||||
Shiller PE Ratio | 34.55 | |||||
Price-to-Owner-Earnings | 35.06 | |||||
PEG Ratio | 0.9 | |||||
PS Ratio | 4.31 | |||||
PB Ratio | 4.24 | |||||
Price-to-Tangible-Book | 11.93 | |||||
Price-to-Operating-Cash-Flow | 54.18 | |||||
EV-to-EBIT | 17.66 | |||||
EV-to-Forward-EBIT | 22.79 | |||||
EV-to-EBITDA | 14.73 | |||||
EV-to-Forward-EBITDA | 17.02 | |||||
EV-to-Revenue | 4.68 | |||||
EV-to-Forward-Revenue | 3.66 | |||||
EV-to-FCF | -218.73 | |||||
Price-to-GF-Value | 1 | |||||
Price-to-Projected-FCF | 2.27 | |||||
Price-to-DCF (Earnings Based) | 1.46 | |||||
Price-to-Median-PS-Value | 1.22 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.89 | |||||
Price-to-Graham-Number | 3.36 | |||||
Earnings Yield (Greenblatt) % | 5.67 | |||||
FCF Yield % | -0.49 | |||||
Forward Rate of Return (Yacktman) % | 21.7 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Zydus Lifesciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 267,197 | ||
| EPS (TTM) (₹) | 50.1 | ||
| Beta | 0.6912 | ||
| 3-Year Sharpe Ratio | 0.68 | ||
| 3-Year Sortino Ratio | 1.43 | ||
| Volatility % | 23.66 | ||
| 14-Day RSI | 65.66 | ||
| 14-Day ATR (₹) | 25.368063 | ||
| 20-Day SMA (₹) | 1110.895 | ||
| 12-1 Month Momentum % | 12.76 | ||
| 52-Week Range (₹) | 835.85 - 1181 | ||
| Shares Outstanding (Mil) | 997.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zydus Lifesciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zydus Lifesciences Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| INR 1.000000 Cash Dividend | 2026-07-24 | In 13 days | ||
| INR 11.000000 Cash Dividend | 2025-07-25 | 971.05 (+0.77%) | ||
| INR 3.000000 Cash Dividend | 2024-07-26 | 1,205.60 (+3.04%) | ||
| 5:1 Stock Split | 2015-10-06 | 416.06 (-2.56%) | ||
| 1.5:1 Stock Split | 2010-04-05 | 110.49 (+0.00%) |
Show
Entries
Zydus Lifesciences Ltd Frequently Asked Questions
What is Zydus Lifesciences Ltd(BOM:532321)'s stock price today?
The current price of BOM:532321 is ₹1150.50. The 52 week high of BOM:532321 is ₹1181.00 and 52 week low is ₹835.85.
When is next earnings date of Zydus Lifesciences Ltd(BOM:532321)?
The next earnings date of Zydus Lifesciences Ltd(BOM:532321) is .
Does Zydus Lifesciences Ltd(BOM:532321) pay dividends? If so, how much?
The Dividend Yield % of Zydus Lifesciences Ltd(BOM:532321) is 0.95% (As of Today), Highest Dividend Payout Ratio of Zydus Lifesciences Ltd(BOM:532321) was 0.52. The lowest was 0.06. And the median was 0.19. The Forward Dividend Yield % of Zydus Lifesciences Ltd(BOM:532321) is 0.09%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Articles on Zydus Lifesciences Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers